Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial

doi:10.1111/bju.15625

Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	68-75
Number of pages	8
Journal	BJU International
Volume	130
Issue number	1
DOIs	https://doi.org/10.1111/bju.15625
Publication status	Published - Jul 2022
Externally published	Yes

ASJC Scopus Subject Areas

Urology

Keywords

#KidneyCancer
#kcsm
#uroonc
cytoreductive nephrectomy
deferred
immediate
renal cell carcinoma
sunitinib
survival

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bju.15625

Cite this

@article{eb15096fe6ea47c3a9f702bd88290b02,

title = "Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial",

keywords = "#KidneyCancer, #kcsm, #uroonc, cytoreductive nephrectomy, deferred, immediate, renal cell carcinoma, sunitinib, survival",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors BJU International {\textcopyright} 2021 BJU International.",

year = "2022",

month = jul,

doi = "10.1111/bju.15625",

language = "English",

volume = "130",

pages = "68--75",

journal = "BJU International",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial

PY - 2022/7

Y1 - 2022/7

KW - #KidneyCancer

KW - #kcsm

KW - #uroonc

KW - cytoreductive nephrectomy

KW - deferred

KW - immediate

KW - renal cell carcinoma

KW - sunitinib

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=85120573848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120573848&partnerID=8YFLogxK

U2 - 10.1111/bju.15625

DO - 10.1111/bju.15625

M3 - Article

AN - SCOPUS:85120573848

SN - 1464-4096

VL - 130

SP - 68

EP - 75

JO - BJU International

JF - BJU International

IS - 1

ER -

Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this